Cargando…
The 2018 Nobel Prize in Medicine for breakthroughs in targeting immune checkpoint inhibitors: a brief perspective
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990146/ https://www.ncbi.nlm.nih.gov/pubmed/33928220 http://dx.doi.org/10.1093/abt/tbz003 |
| _version_ | 1783669021486350336 |
|---|---|
| author | Rios, Adan Salazar, Georgina To'a Zhang, Ningyan An, Zhiqiang |
| author_facet | Rios, Adan Salazar, Georgina To'a Zhang, Ningyan An, Zhiqiang |
| author_sort | Rios, Adan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7990146 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79901462021-04-28 The 2018 Nobel Prize in Medicine for breakthroughs in targeting immune checkpoint inhibitors: a brief perspective Rios, Adan Salazar, Georgina To'a Zhang, Ningyan An, Zhiqiang Antib Ther Editorial Oxford University Press 2019-03-14 /pmc/articles/PMC7990146/ /pubmed/33928220 http://dx.doi.org/10.1093/abt/tbz003 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Antibody Therapeutics. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Editorial Rios, Adan Salazar, Georgina To'a Zhang, Ningyan An, Zhiqiang The 2018 Nobel Prize in Medicine for breakthroughs in targeting immune checkpoint inhibitors: a brief perspective |
| title | The 2018 Nobel Prize in Medicine for breakthroughs in targeting immune checkpoint inhibitors: a brief perspective |
| title_full | The 2018 Nobel Prize in Medicine for breakthroughs in targeting immune checkpoint inhibitors: a brief perspective |
| title_fullStr | The 2018 Nobel Prize in Medicine for breakthroughs in targeting immune checkpoint inhibitors: a brief perspective |
| title_full_unstemmed | The 2018 Nobel Prize in Medicine for breakthroughs in targeting immune checkpoint inhibitors: a brief perspective |
| title_short | The 2018 Nobel Prize in Medicine for breakthroughs in targeting immune checkpoint inhibitors: a brief perspective |
| title_sort | 2018 nobel prize in medicine for breakthroughs in targeting immune checkpoint inhibitors: a brief perspective |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990146/ https://www.ncbi.nlm.nih.gov/pubmed/33928220 http://dx.doi.org/10.1093/abt/tbz003 |
| work_keys_str_mv | AT riosadan the2018nobelprizeinmedicineforbreakthroughsintargetingimmunecheckpointinhibitorsabriefperspective AT salazargeorginatoa the2018nobelprizeinmedicineforbreakthroughsintargetingimmunecheckpointinhibitorsabriefperspective AT zhangningyan the2018nobelprizeinmedicineforbreakthroughsintargetingimmunecheckpointinhibitorsabriefperspective AT anzhiqiang the2018nobelprizeinmedicineforbreakthroughsintargetingimmunecheckpointinhibitorsabriefperspective AT riosadan 2018nobelprizeinmedicineforbreakthroughsintargetingimmunecheckpointinhibitorsabriefperspective AT salazargeorginatoa 2018nobelprizeinmedicineforbreakthroughsintargetingimmunecheckpointinhibitorsabriefperspective AT zhangningyan 2018nobelprizeinmedicineforbreakthroughsintargetingimmunecheckpointinhibitorsabriefperspective AT anzhiqiang 2018nobelprizeinmedicineforbreakthroughsintargetingimmunecheckpointinhibitorsabriefperspective |